114 related articles for article (PubMed ID: 17266044)
21. Oncogenic transformation of human ovarian surface epithelial cells with defined cellular oncogenes.
Sasaki R; Narisawa-Saito M; Yugawa T; Fujita M; Tashiro H; Katabuchi H; Kiyono T
Carcinogenesis; 2009 Mar; 30(3):423-31. PubMed ID: 19126650
[TBL] [Abstract][Full Text] [Related]
22. [ZNF217 gene was detected in ovarian serous cystadenocarcinoma by fluorescence in situ hybridization].
Zhong M; Li J; Ding YQ; Song LL
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Dec; 23(6):665-7. PubMed ID: 17160949
[TBL] [Abstract][Full Text] [Related]
23. Expression and function of HOXA genes in normal and neoplastic ovarian epithelial cells.
Ota T; Klausen C; Salamanca MC; Woo HL; Leung PC; Auersperg N
Differentiation; 2009 Feb; 77(2):162-71. PubMed ID: 19281776
[TBL] [Abstract][Full Text] [Related]
24. Gene amplification of ZNF217 located at chr20q13.2 is associated with lymph node metastasis in ovarian clear cell carcinoma.
Rahman MT; Nakayama K; Rahman M; Katagiri H; Katagiri A; Ishibashi T; Ishikawa M; Iida K; Nakayama N; Otsuki Y; Nakayama S; Miyazaki K
Anticancer Res; 2012 Aug; 32(8):3091-5. PubMed ID: 22843878
[TBL] [Abstract][Full Text] [Related]
25. Progressive changes in Met-dependent signaling in a human ovarian surface epithelial model of malignant transformation.
Wong AS; Roskelley CD; Pelech S; Miller D; Leung PC; Auersperg N
Exp Cell Res; 2004 Sep; 299(1):248-56. PubMed ID: 15302591
[TBL] [Abstract][Full Text] [Related]
26. Prognostic and therapeutic impact of the chromosome 20q13.2 ZNF217 locus amplification in ovarian clear cell carcinoma.
Rahman MT; Nakayama K; Rahman M; Nakayama N; Ishikawa M; Katagiri A; Iida K; Nakayama S; Otsuki Y; Shih IeM; Miyazaki K
Cancer; 2012 Jun; 118(11):2846-57. PubMed ID: 22139760
[TBL] [Abstract][Full Text] [Related]
27. Sheep stromal-epithelial cell interactions and ovarian tumor progression.
Wang-Johanning F; Huang M; Liu J; Rycaj K; Plummer JB; Barnhart KF; Satterfield WC; Johanning GL
Int J Cancer; 2007 Nov; 121(10):2346-54. PubMed ID: 17657741
[TBL] [Abstract][Full Text] [Related]
28. ZNF217 suppresses cell death associated with chemotherapy and telomere dysfunction.
Huang G; Krig S; Kowbel D; Xu H; Hyun B; Volik S; Feuerstein B; Mills GB; Stokoe D; Yaswen P; Collins C
Hum Mol Genet; 2005 Nov; 14(21):3219-25. PubMed ID: 16203743
[TBL] [Abstract][Full Text] [Related]
29. [ZNF217 expression correlates with the biological behavior of human ovarian cancer cells].
Li J; Song LL; Zhong M
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):170-4. PubMed ID: 23879995
[TBL] [Abstract][Full Text] [Related]
30. ZNF217 is associated with poor prognosis and enhances proliferation and metastasis in ovarian cancer.
Li J; Song L; Qiu Y; Yin A; Zhong M
Int J Clin Exp Pathol; 2014; 7(6):3038-47. PubMed ID: 25031722
[TBL] [Abstract][Full Text] [Related]
31. Human steroidogenic factor-1 (hSF-1) regulates progesterone biosynthesis and growth of ovarian surface epithelial cancer cells.
Ramayya MS; Sheng M; Moroz K; Hill SM; Rowan BG
J Steroid Biochem Mol Biol; 2010 Mar; 119(1-2):14-25. PubMed ID: 20045459
[TBL] [Abstract][Full Text] [Related]
32. Learning the local Bayesian network structure around the ZNF217 oncogene in breast tumours.
Prestat E; de Morais SR; Vendrell JA; Thollet A; Gautier C; Cohen PA; Aussem A
Comput Biol Med; 2013 May; 43(4):334-41. PubMed ID: 23375235
[TBL] [Abstract][Full Text] [Related]
33. Characterization and tumorigenicity of human ovarian surface epithelial cells immortalized by SV40 large T antigen.
Nitta M; Katabuchi H; Ohtake H; Tashiro H; Yamaizumi M; Okamura H
Gynecol Oncol; 2001 Apr; 81(1):10-7. PubMed ID: 11277643
[TBL] [Abstract][Full Text] [Related]
34. Differentially regulated genes as putative targets of amplifications at 20q in ovarian cancers.
Watanabe T; Imoto I; Katahira T; Hirasawa A; Ishiwata I; Emi M; Takayama M; Sato A; Inazawa J
Jpn J Cancer Res; 2002 Oct; 93(10):1114-22. PubMed ID: 12417041
[TBL] [Abstract][Full Text] [Related]
35. Profiling estrogen-regulated gene expression changes in normal and malignant human ovarian surface epithelial cells.
Syed V; Zhang X; Lau KM; Cheng R; Mukherjee K; Ho SM
Oncogene; 2005 Dec; 24(55):8128-43. PubMed ID: 16116479
[TBL] [Abstract][Full Text] [Related]
36. Serial propagation of human ovarian surface epithelium in tissue culture.
Siemens CH; Auersperg N
J Cell Physiol; 1988 Mar; 134(3):347-56. PubMed ID: 2450877
[TBL] [Abstract][Full Text] [Related]
37. Transforming growth factor alpha production and epidermal growth factor receptor expression in normal and oncogene transformed human mammary epithelial cells.
Valverius EM; Bates SE; Stampfer MR; Clark R; McCormick F; Salomon DS; Lippman ME; Dickson RB
Mol Endocrinol; 1989 Jan; 3(1):203-14. PubMed ID: 2783757
[TBL] [Abstract][Full Text] [Related]
38. Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells.
Sato M; Vaughan MB; Girard L; Peyton M; Lee W; Shames DS; Ramirez RD; Sunaga N; Gazdar AF; Shay JW; Minna JD
Cancer Res; 2006 Feb; 66(4):2116-28. PubMed ID: 16489012
[TBL] [Abstract][Full Text] [Related]
39. Epithelial-mesenchymal interconversions in normal ovarian surface epithelium and ovarian carcinomas: an exception to the norm.
Ahmed N; Thompson EW; Quinn MA
J Cell Physiol; 2007 Dec; 213(3):581-8. PubMed ID: 17708542
[TBL] [Abstract][Full Text] [Related]
40. Pregnancy-associated plasma protein-A (PAPP-A) expression and insulin-like growth factor binding protein-4 protease activity in normal and malignant ovarian surface epithelial cells.
Kalli KR; Chen BK; Bale LK; Gernand E; Overgaard MT; Oxvig C; Cliby WA; Conover CA
Int J Cancer; 2004 Jul; 110(5):633-40. PubMed ID: 15146551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
